fbpx
March 18, 2024

Novel Drug Approvals for 2018

No. DrugName Active Ingredient Approval Date FDA-approved use on approval date* 59. Ultomiris ravulizumab 12/21/2018 To treat paroxysmal nocturnal hemoglobinuria (PNH)Press ReleaseDrug Trials Snapshot 58. Elzonris […]
March 18, 2024

Novel Drug Approvals for 2019

Helping Guide the Way for New Medicines Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0